Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 08, 2016 2:31 AM ET

Company Overview of Takeda Pharmaceuticals International, Inc

Company Overview


United States

Key Executives for Takeda Pharmaceuticals International, Inc

President, Chief Administrative Officer and Managing Director
President of Global Vaccine Business Unit
Executive Vice President of International Operations - Americas & Europe and Director
Age: 62
Managing Director and Senior Vice President of Pharmaceutical Marketing Division
Executive Vice President, Medical & Scientific Advisor to the Chief Executive Officer and Director
Age: 69
Compensation as of Fiscal Year 2015.

Takeda Pharmaceuticals International, Inc Key Developments

Takeda Pharmaceuticals International, Inc Presents at Bio-Trinity, May-12-2015 10:10 AM

Takeda Pharmaceuticals International, Inc Presents at Bio-Trinity, May-12-2015 10:10 AM. Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom. Speakers: Terence Porter, VP Global Search & Evaluation.

Takeda Pharmaceuticals International, Inc Announces Executive Changes

Takeda Pharmaceuticals International Inc. announced that John Boslego, MD, has been named Senior Vice President and Head of Development for Takeda's Global Vaccine Business Unit, effective December 1, 2014. He will succeed Ralf Clemens, MD, who has served in this role since the launch of Takeda's Vaccine Business Division in January 2012. Dr. Boslego will be responsible for accelerating global vaccine development activities at Takeda, with a focus on lead development programs for dengue, norovirus and seasonal influenza. He will report to Rajeev Venkayya, MD, President of Takeda's Global Vaccine Business Unit. Dr. Boslego has worked for more than 40 years in vaccine clinical research and development. Most recently, he was the Director of the Vaccine Development Global Program at PATH.

Similar Private Companies By Industry

Company Name Region
Pristine Hydrochemical Inc. United States
Ascendiant Capital Group LLC United States
CWS Treetops - Lodge TVL, L.P. United States
Carr Realty Corp United States
Mass. DOI United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Takeda Pharmaceuticals International, Inc, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at